GPT and metabolic dysfunction-associated steatotic liver disease: For the remaining 161 patients, BMI, WHR, SBP, DBP, HbA1c, FPG, 2hPG, FIns, FCP, TG, TC, LDL-C, HDL-C, ALT, AST, GGT, and HOMA-IR in patients with NAFLD were significantly higher than the non-NAFLD group (p < 0.05); however, HDL-c and HOMA-β were significantly lower than the control group (p < 0.05).